Bellevue Ag 13F annual report
Bellevue Ag is an investment fund managing more than $6.15 trillion ran by Christoph Montalbano. There are currently 166 companies in Mr. Montalbano’s portfolio. The largest investments include Ionis Pharmaceuticals Inc and Argenx Se, together worth $691 billion.
$6.15 trillion Assets Under Management (AUM)
As of 7th August 2024, Bellevue Ag’s top holding is 8,260,434 shares of Ionis Pharmaceuticals Inc currently worth over $394 billion and making up 6.4% of the portfolio value.
Relative to the number of outstanding shares of Ionis Pharmaceuticals Inc, Bellevue Ag owns less than approximately 0.1% of the company.
In addition, the fund holds 691,874 shares of Argenx Se worth $298 billion.
The third-largest holding is Vertex Pharmaceuticals worth $278 billion and the next is Neurocrine Biosciences worth $261 billion, with 1,898,640 shares owned.
Currently, Bellevue Ag's portfolio is worth at least $6.15 trillion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Bellevue Ag
The Bellevue Ag office and employees reside in Kuesnacht, Switzerland. According to the last 13-F report filed with the SEC, Christoph Montalbano serves as the Head Legal & Compliance / CFO at Bellevue Ag.
Recent trades
In the most recent 13F filing, Bellevue Ag revealed that it had opened a new position in
Edgewise Therapeutics Inc and bought 1,428,929 shares worth $25.7 billion.
The investment fund also strengthened its position in Alnylam Pharmaceuticals Inc by buying
1,550 additional shares.
This makes their stake in Alnylam Pharmaceuticals Inc total 919,834 shares worth $224 billion.
Alnylam Pharmaceuticals Inc soared 47.6% in the past year.
On the other hand, there are companies that Bellevue Ag is getting rid of from its portfolio.
Bellevue Ag closed its position in Shockwave Med Inc on 14th August 2024.
It sold the previously owned 105,786 shares for $34.4 billion.
Christoph Montalbano also disclosed a decreased stake in Ionis Pharmaceuticals Inc by approximately 0.1%.
This leaves the value of the investment at $394 billion and 8,260,434 shares.
One of the largest hedge funds
The two most similar investment funds to Bellevue Ag are Bristol John W & Co Inc ny/ and Mediolanum International Funds Ltd. They manage $6.18 trillion and $6.11 trillion respectively.
Christoph Montalbano investment strategy
Bellevue Ag’s portfolio is diversified across 6 sectors.
Currently, their heaviest sector is Health Care — making up 80.4% of
the total portfolio value.
The fund focuses on investments in the United States as
68.1% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
34% of the total holdings value.
On the other hand, small-cap stocks make up only 0.6% of the portfolio.
The average market cap of the portfolio companies is close to $84.6 billion.
The complete list of Bellevue Ag trades based on 13F SEC filings
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Ionis Pharmaceuticals Inc |
0.47%
8,260,434
|
$393,692,284,000 | 6.40% |
| Argenx Se |
14.69%
691,874
|
$297,533,495,000 | 4.83% |
| Vertex Pharmaceuticals, Inc. |
11.26%
593,461
|
$278,167,040,000 | 4.52% |
| Neurocrine Biosciences, Inc. |
7.65%
1,898,640
|
$261,385,769,000 | 4.25% |
| Intuitive Surgical Inc |
20.86%
539,904
|
$240,176,295,000 | 3.90% |
| Alnylam Pharmaceuticals Inc |
0.17%
919,834
|
$223,519,662,000 | 3.63% |
| Boston Scientific Corp. |
18.39%
2,569,588
|
$197,883,972,000 | 3.22% |
| Revolution Medicines Inc |
0.88%
5,029,100
|
$195,179,371,000 | 3.17% |
| Stryker Corp. |
21.50%
545,934
|
$185,754,044,000 | 3.02% |
| Moderna Inc |
8.61%
1,563,735
|
$185,693,531,000 | 3.02% |
| Intra-Cellular Therapies Inc |
12.35%
2,471,285
|
$169,258,310,000 | 2.75% |
| Agios Pharmaceuticals Inc |
3.16%
3,879,548
|
$167,286,110,000 | 2.72% |
| Abbott Labs |
11.99%
1,606,153
|
$166,895,358,000 | 2.71% |
| Dexcom Inc |
3.89%
1,268,687
|
$143,843,733,000 | 2.34% |
| Incyte Corp. |
0.01%
2,153,504
|
$130,545,412,000 | 2.12% |
| Edwards Lifesciences Corp |
14.26%
1,260,461
|
$116,428,783,000 | 1.89% |
| Celldex Therapeutics Inc. |
6.26%
2,971,615
|
$109,979,471,000 | 1.79% |
| Unitedhealth Group Inc |
38.30%
205,675
|
$104,742,050,000 | 1.70% |
| Insulet Corporation |
48.19%
435,420
|
$87,867,756,000 | 1.43% |
| Becton Dickinson & Co. |
16.45%
347,333
|
$81,175,195,000 | 1.32% |
| Medtronic Plc |
0.52%
1,001,747
|
$78,847,506,000 | 1.28% |
| Biohaven Ltd |
77.47%
2,040,853
|
$70,838,008,000 | 1.15% |
| Insmed Inc |
52.30%
1,021,700
|
$68,453,900,000 | 1.11% |
| Arvinas Inc |
No change
2,390,800
|
$63,643,096,000 | 1.03% |
| Tandem Diabetes Care Inc |
24.05%
1,543,267
|
$62,178,227,000 | 1.01% |
| Caredx Inc |
0.54%
3,912,575
|
$60,762,290,000 | 0.99% |
| Elevance Health Inc |
2.98%
101,549
|
$55,025,341,000 | 0.89% |
| Penumbra Inc |
55.69%
282,049
|
$50,760,359,000 | 0.82% |
| Exact Sciences Corp. |
1.79%
1,158,880
|
$48,962,680,000 | 0.80% |
| Zimmer Biomet Holdings Inc |
59.13%
449,081
|
$48,738,761,000 | 0.79% |
| Sage Therapeutics Inc |
0.02%
4,464,693
|
$48,486,566,000 | 0.79% |
| Charles Riv Labs Intl Inc |
1.31%
232,702
|
$48,071,579,000 | 0.78% |
| Idexx Labs Inc |
No change
93,358
|
$45,484,018,000 | 0.74% |
| Eli Lilly & Co |
14.30%
49,674
|
$44,973,846,000 | 0.73% |
| Bio Rad Labs Inc |
0.87%
155,258
|
$42,402,512,000 | 0.69% |
| Macrogenics Inc |
0.24%
9,942,313
|
$42,254,831,000 | 0.69% |
| Axsome Therapeutics Inc |
24.65%
516,533
|
$41,580,907,000 | 0.68% |
| Relay Therapeutics, Inc. |
7.60%
6,377,115
|
$41,578,790,000 | 0.68% |
| Essa Pharma Inc |
No change
7,889,583
|
$41,499,207,000 | 0.67% |
| Procept Biorobotics Corp |
24.84%
669,049
|
$40,872,203,000 | 0.66% |
| Cigna Group (The) |
54.55%
123,090
|
$40,689,861,000 | 0.66% |
| Ge Healthcare Technologies I |
1.72%
521,017
|
$40,597,645,000 | 0.66% |
| Exelixis Inc |
5.25%
1,803,200
|
$40,517,904,000 | 0.66% |
| Sarepta Therapeutics Inc |
0.32%
252,321
|
$39,866,718,000 | 0.65% |
| Black Diamond Therapeutics I |
No change
8,517,839
|
$39,693,130,000 | 0.64% |
| HCA Healthcare Inc |
23.42%
122,304
|
$39,293,829,000 | 0.64% |
| Option Care Health, Inc. |
24.12%
1,416,879
|
$39,247,548,000 | 0.64% |
| Immunocore Hldgs Plc |
18.76%
1,154,654
|
$39,131,224,000 | 0.64% |
| Align Technology, Inc. |
7.05%
143,982
|
$34,761,574,000 | 0.56% |
| Cooper Cos Inc |
No change
397,373
|
$34,690,663,000 | 0.56% |
| Shockwave Med Inc |
Closed
105,786
|
$34,447,095,000 | |
| Globus Med Inc |
14.24%
497,293
|
$34,059,598,000 | 0.55% |
| Regeneron Pharmaceuticals, Inc. |
356.37%
32,297
|
$33,945,116,000 | 0.55% |
| CRISPR Therapeutics AG |
0.37%
617,649
|
$33,359,222,000 | 0.54% |
| Beam Therapeutics Inc. |
18.86%
1,418,121
|
$33,226,575,000 | 0.54% |
| Evolent Health Inc |
12.59%
1,669,835
|
$31,927,246,000 | 0.52% |
| Veeva Sys Inc |
0.20%
168,583
|
$30,852,375,000 | 0.50% |
| TransMedics Group, Inc. |
44.68%
201,415
|
$30,337,127,000 | 0.49% |
| Resmed Inc. |
412.92%
155,881
|
$29,838,741,000 | 0.48% |
| Centene Corp. |
16.07%
421,458
|
$27,942,665,000 | 0.45% |
| Mckesson Corporation |
412.86%
46,142
|
$26,948,774,000 | 0.44% |
| Castle Biosciences, Inc. |
0.24%
1,217,101
|
$26,496,289,000 | 0.43% |
| Edgewise Therapeutics Inc |
Opened
1,428,929
|
$25,735,011,000 | 0.42% |
| Annexon Inc |
136.32%
5,157,290
|
$25,270,721,000 | 0.41% |
| Thermo Fisher Scientific Inc. |
6.68%
42,626
|
$23,572,178,000 | 0.38% |
| Natera Inc |
20.70%
213,987
|
$23,172,652,000 | 0.38% |
| Silk Rd Med Inc |
43.67%
855,293
|
$23,127,123,000 | 0.38% |
| Molina Healthcare Inc |
23.52%
76,393
|
$22,711,639,000 | 0.37% |
| Esperion Therapeutics Inc Ne |
No change
9,944,064
|
$22,075,822,000 | 0.36% |
| Structure Therapeutics Inc |
53.14%
557,321
|
$21,885,996,000 | 0.36% |
| Danaher Corp. |
2.68%
83,920
|
$20,967,412,000 | 0.34% |
| Wave Life Sciences Ltd. |
No change
4,094,458
|
$20,431,345,000 | 0.33% |
| Cencora Inc. |
32.07%
89,329
|
$20,125,824,000 | 0.33% |
| Steris Plc |
24.30%
91,282
|
$20,040,050,000 | 0.33% |
| Hutchmed China Ltd |
0.47%
1,149,157
|
$19,673,567,000 | 0.32% |
| IQVIA Holdings Inc |
1,004.64%
92,083
|
$19,470,030,000 | 0.32% |
| Privia Health Group Inc |
No change
1,059,171
|
$18,408,392,000 | 0.30% |
| Hologic, Inc. |
14.53%
247,826
|
$18,401,081,000 | 0.30% |
| Scholar Rock Hldg Corp |
No change
2,165,203
|
$18,036,141,000 | 0.29% |
| SI-BONE Inc |
21.72%
1,387,609
|
$17,941,784,000 | 0.29% |
| Pacific Biosciences Calif In |
Closed
4,592,251
|
$17,220,942,000 | |
| Apellis Pharmaceuticals Inc |
6.23%
444,404
|
$17,047,337,000 | 0.28% |
| Inspire Med Sys Inc |
42.71%
124,724
|
$16,691,813,000 | 0.27% |
| Neogenomics Inc. |
27.07%
1,202,096
|
$16,673,072,000 | 0.27% |
| Verona Pharma Plc |
0.44%
1,134,229
|
$16,400,951,000 | 0.27% |
| Legend Biotech Corp |
25.91%
369,270
|
$16,354,968,000 | 0.27% |
| Fate Therapeutics Inc |
No change
4,839,779
|
$15,874,475,000 | 0.26% |
| Generation Bio Co. |
1.48%
3,918,856
|
$11,051,174,000 | 0.18% |
| Humana Inc. |
79.02%
28,440
|
$10,626,606,000 | 0.17% |
| Astrana Health Inc |
2,343.61%
250,617
|
$10,165,026,000 | 0.17% |
| Phreesia Inc |
No change
443,341
|
$9,398,829,000 | 0.15% |
| Merck & Co Inc |
75.97%
74,709
|
$9,248,974,000 | 0.15% |
| AMGEN Inc. |
33.38%
29,528
|
$9,226,024,000 | 0.15% |
| Abbvie Inc |
52.95%
42,204
|
$7,238,830,000 | 0.12% |
| Glaukos Corporation |
No change
55,926
|
$6,618,842,000 | 0.11% |
| Omnicell Com |
No change
235,372
|
$6,371,520,000 | 0.10% |
| 10x Genomics, Inc. |
No change
308,311
|
$5,996,649,000 | 0.10% |
| Atricure Inc |
52.49%
212,559
|
$4,839,968,000 | 0.08% |
| Illumina Inc |
No change
43,596
|
$4,550,550,000 | 0.07% |
| Biomarin Pharmaceutical Inc. |
83.77%
52,232
|
$4,300,261,000 | 0.07% |
| Altimmune Inc |
Opened
600,000
|
$3,990,000,000 | 0.06% |
| BeiGene Ltd |
2.81%
25,629
|
$3,656,489,000 | 0.06% |
| Spdr S&p 500 Etf Tr |
Closed
6,660
|
$3,483,646,000 | |
| Astrazeneca plc |
81.90%
42,200
|
$3,291,178,000 | 0.05% |
| Waystar Hldg Corp |
Opened
150,000
|
$3,225,000,000 | 0.05% |
| Cardinal Health, Inc. |
986.07%
32,582
|
$3,203,462,000 | 0.05% |
| Recursion Pharmaceuticals In |
0.13%
425,810
|
$3,193,575,000 | 0.05% |
| Accolade, Inc. |
82.46%
842,577
|
$3,016,426,000 | 0.05% |
| Outset Med Inc |
33.27%
762,799
|
$2,936,776,000 | 0.05% |
| Gilead Sciences, Inc. |
16.90%
38,934
|
$2,671,262,000 | 0.04% |
| Teladoc Health Inc |
No change
272,798
|
$2,667,964,000 | 0.04% |
| Teva Pharmaceutical Inds Ltd |
8.83%
154,770
|
$2,515,013,000 | 0.04% |
| Pfizer Inc. |
161.91%
88,614
|
$2,479,420,000 | 0.04% |
| Doximity, Inc. |
49.91%
72,155
|
$2,018,175,000 | 0.03% |
| Dr Reddys Labs Ltd |
42.96%
23,328
|
$1,777,360,000 | 0.03% |
| Molecular Templates Inc |
24.28%
1,279,820
|
$1,471,793,000 | 0.02% |
| Biogen Inc |
1.76%
5,902
|
$1,368,202,000 | 0.02% |
| Certara, Inc. |
No change
95,924
|
$1,328,547,000 | 0.02% |
| CVS Health Corp |
No change
22,066
|
$1,303,218,000 | 0.02% |
| Bristol-Myers Squibb Co. |
Closed
23,436
|
$1,270,934,000 | |
| Encompass Health Corp |
7.42%
13,868
|
$1,189,736,000 | 0.02% |
| Johnson & Johnson |
21.45%
7,797
|
$1,139,610,000 | 0.02% |
| Nevro Corp |
No change
135,235
|
$1,138,679,000 | 0.02% |
| Alphabet Inc |
No change
6,000
|
$1,100,520,000 | 0.02% |
| Vaxcyte, Inc. |
7.29%
14,210
|
$1,072,997,000 | 0.02% |
| VanEck ETF Trust |
Closed
33,000
|
$1,043,460,000 | |
| Cytokinetics Inc |
6.52%
16,659
|
$902,585,000 | 0.01% |
| Krystal Biotech Inc |
12.72%
4,198
|
$770,921,000 | 0.01% |
| Tenet Healthcare Corp. |
27.57%
5,414
|
$720,224,000 | 0.01% |
| Merus N.V |
No change
9,800
|
$579,866,000 | 0.01% |
| Blueprint Medicines Corp |
No change
5,100
|
$549,678,000 | 0.01% |
| Rhythm Pharmaceuticals Inc. |
4.00%
13,000
|
$533,780,000 | 0.01% |
| Protagonist Therapeutics Inc |
20.89%
15,146
|
$524,809,000 | 0.01% |
| Zoetis Inc |
60.84%
2,941
|
$509,852,000 | 0.01% |
| Apple Inc |
No change
2,200
|
$463,364,000 | 0.01% |
| Alkermes plc |
25.45%
18,000
|
$433,800,000 | 0.01% |
| Rocket Pharmaceuticals Inc |
No change
19,700
|
$424,141,000 | 0.01% |
| Amneal Pharmaceuticals Inc |
38.28%
62,760
|
$398,526,000 | 0.01% |
| Xenon Pharmaceuticals Inc |
27.66%
10,200
|
$397,698,000 | 0.01% |
| Verve Therapeutics Inc |
Closed
29,200
|
$387,776,000 | |
| Adma Biologics Inc |
24.45%
30,900
|
$345,462,000 | 0.01% |
| Viridian Therapeutics Inc |
Closed
19,100
|
$334,441,000 | |
| 4d Molecular Therapeutics In |
No change
15,700
|
$329,543,000 | 0.01% |
| BridgeBio Pharma Inc |
No change
12,800
|
$324,224,000 | 0.01% |
| Bicycle Therapeutics plc |
28.00%
16,000
|
$323,840,000 | 0.01% |
| Dynavax Technologies Corp. |
No change
27,558
|
$309,476,000 | 0.01% |
| Madrigal Pharmaceuticals Inc |
3.77%
1,100
|
$308,176,000 | 0.01% |
| Viatris Inc. |
82.78%
26,531
|
$282,025,000 | 0.00% |
| Simply Good Foods Co |
Closed
7,900
|
$268,837,000 | |
| C4 Therapeutics, Inc. |
No change
57,600
|
$266,112,000 | 0.00% |
| Biomea Fusion Inc |
Closed
17,800
|
$266,110,000 | |
| Nike, Inc. |
Opened
3,500
|
$263,795,000 | 0.00% |
| Regenxbio Inc |
Closed
12,000
|
$252,840,000 | |
| Viking Therapeutics Inc |
18.52%
4,400
|
$233,244,000 | 0.00% |
| Kura Oncology Inc |
Opened
10,000
|
$205,900,000 | 0.00% |
| Mineralys Therapeutics Inc |
90.21%
17,499
|
$204,738,000 | 0.00% |
| IDEAYA Biosciences, Inc. |
72.73%
5,700
|
$200,127,000 | 0.00% |
| 89bio Inc |
80.29%
24,700
|
$197,847,000 | 0.00% |
| Moonlake Immunotherapeutics |
No change
4,400
|
$193,468,000 | 0.00% |
| Baxter International Inc. |
Closed
4,200
|
$179,508,000 | |
| Tempus Ai Inc |
Opened
5,000
|
$175,000,000 | 0.00% |
| Baidu Inc |
No change
2,000
|
$172,960,000 | 0.00% |
| West Pharmaceutical Svsc Inc |
40.23%
520
|
$171,283,000 | 0.00% |
| Garmin Ltd |
62.50%
1,050
|
$171,066,000 | 0.00% |
| Ultragenyx Pharmaceutical In |
Opened
4,000
|
$164,400,000 | 0.00% |
| Arcutis Biotherapeutics Inc |
Opened
17,500
|
$162,750,000 | 0.00% |
| Autolus Therapeutics plc |
No change
32,500
|
$113,100,000 | 0.00% |
| Grail Inc |
Opened
7,266
|
$111,678,000 | 0.00% |
| Agilent Technologies Inc. |
30.37%
704
|
$91,260,000 | 0.00% |
| NVIDIA Corp |
575.26%
655
|
$80,919,000 | 0.00% |
| Oracle Corp. |
15.66%
571
|
$80,625,000 | 0.00% |
| Microsoft Corporation |
0.56%
179
|
$80,004,000 | 0.00% |
| Qualcomm, Inc. |
24.37%
391
|
$77,879,000 | 0.00% |
| Mettler-Toledo International, Inc. |
21.21%
40
|
$55,904,000 | 0.00% |
| Omniab Inc |
No change
11,456
|
$42,960,000 | 0.00% |
| Labcorp Holdings Inc. |
Opened
190
|
$38,667,000 | 0.00% |
| Laboratory Corp Amer Hldgs |
Closed
148
|
$32,332,000 | |
| Exscientia Plc |
26.70%
3,350
|
$17,085,000 | 0.00% |
| Ionq Inc |
Closed
1,107
|
$11,059,000 | |
| No transactions found | |||
| Showing first 500 out of 179 holdings | |||
Hedge funds similar to Bellevue Ag
- Lgt Foundation
- Pinnacle Associates Ltd
- Moneta Group Investment Advisors
- Lyrical Asset Management L.P.
- Financial Counselors Inc
- Briar Hall Management
- Bristol John W & Co Inc ny/
- Mediolanum International Funds Ltd
- Leonard Green & Partners, L.P.
- Umb Bank, N.a
- Stratos Wealth Partners, Ltd
- Cincinnati Insurance Co
- Tocqueville Asset Management L.P.
- Stifel Nicolaus & Co Inc \mo\